Last updated: June 21, 2021
Sponsor: AB Biotics, SA
Overall Status: Completed
Phase
N/A
Condition
Colic
Bowel Dysfunction
Constipation
Treatment
N/AClinical Study ID
NCT04944628
Normocolic ADL
Ages 1-10 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with gastrointestinal symptoms related to FGID including functionalconstipation and/or infant colic diagnosed according to Rome IV criteria for clinicalpurposes.
- ≥ 37 weeks of gestation at birth.
- ≥ 2500 g of birth weight.
Exclusion
Exclusion Criteria:
- Infants with failure to thrive (weight gain <100 grams/week on average from birth).
- Major medical problems (e. g. immunodeficiencies, developmental problems or geneticabnormalities)
- Gastrointestinal diseases
- Administered with antibiotics for 4 weeks or probiotics for 2 weeks before or duringstudy
Study Design
Total Participants: 36
Study Start date:
August 15, 2018
Estimated Completion Date:
December 05, 2018
Study Description
Connect with a study center
Azienda Sanitaria Locale Napoli
Naples,
ItalySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.